Skip to main content
Explore URMC
menu

A Disease Registry of Patients With Mantle Cell Lymphoma

Research Question:
What are the treatment patterns, physician-reported clinical outcomes, and patient-reported health-related quality of life among patients diagnosed with Mantle Cell Lymphoma (MCL) who initiated a new therapy in the past 3 months?

Basic Study Information

Purpose:
The purpose of this study is to create a patient registry in order to assess treatment patterns, physician-reported clinical outcomes and patient-reported health-related quality of life among patients diagnosed with Mantle Cell Lymphoma (MCL). Eligible patients will have newly initiated a novel therapy in the past 3 months with treatment ongoing at the time of enrollment.

Location: University of Rochester Medical Center
Study Reference #: ILYM19013

Lead Researcher (Principal Investigator)

Lead Researcher: Paul Barr

Study Contact Information

Study Coordinator: Krista French
Phone: (585) 276-5812
Email: Krista_French@URMC.Rochester.edu

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search